SHSm Naimul Hasan

Sm Naimul Hasan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sm Naimul Hasan has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of demographic, environmental, socioeconomic, and government intervention on the spreading of COVID-19

    by Fazla Rabbi Mashrur, Amit Dutta Roy, Anisha Parsub Chhoan, Sumit Sarker, Anamika Saha, S.M. Naimul Hasan, Shumit Saha


  • Open Access

    Electron cryomicroscopy observation of acyl carrier protein translocation in type I fungal fatty acid synthase

    by Jennifer W. Lou, Kali R. Iyer, S. M. Naimul Hasan, Leah E. Cowen, Mohammad T. Mazhab-Jafari

    During fatty acid biosynthesis, acyl carrier proteins (ACPs) from type I fungal fatty acid synthase (FAS) shuttle substrates and intermediates within a reaction chamber that hosts multiple spatially-fixed catalytic centers. A major challenge in understanding the mechanism of ACP-mediated substrate shuttling is experimental observation of its transient interaction landscape within the reaction chamber. Here, we have shown that ACP spatial distribution is sensitive to the presence of substrates in a catalytically inhibited state, which enables high-resolution investigation of the ACP-dependent conformational transitions within the enoyl reductase (ER) reaction site. In two fungal FASs with distinct ACP localization, the shuttling domain is targeted to the ketoacyl-synthase (KS) domain and away from other catalytic centers, such as acetyl-transferase (AT) and ER domains by steric blockage of the KS active site followed by addition of substrates. These studies strongly suggest that acylation of phosphopantetheine arm of ACP may be an integral part of the substrate shuttling mechanism in type I fungal FAS.


  • Open Access

    Mutations in HYAL2, Encoding Hyaluronidase 2, Cause a Syndrome of Orofacial Clefting and Cor Triatriatum Sinister in Humans and Mice

    by Martina M A Muggenthaler, Biswajit Chowdhury, S Naimul Hasan, Harold E Cross, Brian Mark, Gaurav V Harlalka, Michael A Patton, Miho Ishida, Elijah R Behr, Sanjay Sharma, et al.

    Orofacial clefting is amongst the most common of birth defects, with both genetic and environmental components. Although numerous studies have been undertaken to investigate the complexities of the genetic etiology of this heterogeneous condition, this factor remains incompletely understood. Here, we describe mutations in the HYAL2 gene as a cause of syndromic orofacial clefting. HYAL2, encoding hyaluronidase 2, degrades extracellular hyaluronan, a critical component of the developing heart and palatal shelf matrix. Transfection assays demonstrated that the gene mutations destabilize the molecule, dramatically reducing HYAL2 protein levels. Consistent with the clinical presentation in affected individuals, investigations of Hyal2-/- mice revealed craniofacial abnormalities, including submucosal cleft palate. In addition, cor triatriatum sinister and hearing loss, identified in a proportion of Hyal2-/- mice, were also found as incompletely penetrant features in affected humans. Taken together our findings identify a new genetic cause of orofacial clefting in humans and mice, and define the first molecular cause of human cor triatriatum sinister, illustrating the fundamental importance of HYAL2 and hyaluronan turnover for normal human and mouse development. Cleft lip and palate (CLP) is one of the most common congenital anomalies worldwide. Most of the time the cause is unknown. Affected individuals have multiple problems including difficulties with feeding and speech and have to undergo several operations to correct the orofacial cleft. We describe mutations in an enzyme involved in the development of the palate and heart (Hyaluronidase 2, HYAL2) as the cause of a syndrome of CLP and a congenital heart anomaly (cor triatriatum sinister, CTS) in families from the Amish community and Northern Saudi Arabia of Arabic ethnicity. Mice who lack this enzyme show similar features. HYAL2 is involved in the metabolism of hyaluronic acid, which is important in many tissues of the body. By illustrating a lack of HYAL2 causes CLP and CTS we have demonstrated the importance of HYAL2 for the normal development of the palate and heart, improving our understanding of the complex mechanisms involved in the pathogenesis of CLP and CTS which may ultimately contribute to the development of novel therapies to treat these congenital anomalies.


  • Open Access

    Predicted structure model of bungarotoxin from Bungarus fasciatus snake

    by Zahida Yesmin Roly, Sm Naimul Hasan, Kmkb Ferdaus, Abu Reza

    Snake venoms are cocktails comprising combinations of different proteins, peptides, enzymes and toxins. Snake toxins have diverse characteristics having different molecular configuration, structure and mode of action. Many toxins derived from snake venom have distinct pharmacological activities. Venom from Bungarus fasciatus (commonly known as banded krait) is a species of elapid snake found on the South East Asia and Indian sub-continent, mainly contains neurotoxins. Beta bungartotoxin is the major fraction of Bungarus venom and particularly act pre-synaptically by obstructing neurotransmitter release. This toxin in other snake species functionally forms a heterodimer containing two different subunits (A and B). Dimerization of these two chains is a pre-requisite for the proper functionality of this protein. However, B. fasciatus bungartotoxin contains only B chain and their structural orientation in yet to be resolved. Therefore, it is of interest to describe the predicted structure model of the toxin for functional insights. In this work we analyzed the neurotoxic nature, their alignments, secondary and three dimensional structures, functions, active sites and stability with the help of different bioinformatical tools. A comprehensive analysis of the predicted model provides approaching to the functional interpretation of its molecular action.


  • Open Access

    Drifted catalytic properties of β-lactamases due to unconstrained use of antibiotics

    by Rashed Zaman, Pranab Karmaker, Sm Naimul Hasan, M Hamidur Rahman, Ariful Haque

    Context: Antibiotic resistance is an old problem with new face as the rate of infections due to multidrug resistant bacteria is increasing everyday and the number of new antibiotics to overwhelm the problem is becoming smaller. Major mechanism beneath this growing resistance is concomitant with the changes in ?-lactamases catalytic activity and its functional enhancement. Objectives: In ?-lactamases secreting clinical isolates at least 10% are extended-spectrum ?-lactamases (ESBL) that are not even treatable with ?-lactamases inhibitor like clavulanic acids. This implies that the catalytic domains of ?-lactamases have been mutated towards higher pathogenicity. The aim of the present study is to define the changes in ?-lactamases catalytic efficiency against ?-lactam antibiotics and its inhibitors. Materials and Methods: In this research work we have used multiple drug resistant (MDR) strains from surgical site of infections. A rapid method was used for specific detection of bacterial ?-lactamases that uses ?-lactam antibiotics as substrates. In this, the end products (open beta-lactam ring forms) generated after separately incubating substrates with ?-lactamases producing strains. Those end products of antibiotics were highly fluorescent after specific treatment and could be analyzed visually under long-wave UV lamp for efficiency. Results: ?-lactamases secreting strains are variably capable of defending ?-lactam antibiotics. Interestingly, one of the E. coli strain secretes ESBL, this means that the strain is resistant against clavulanic acid. However, the most fascinating fact of the finding is that ideally the ?-lactamases supposed to hydrolyze Penicillin by default but in our isolates, ?-lactamases are not able to hydrolyze penicillin instead they hydrolyze amoxicillin, a derivative which replaced clinical use of penicillin. In addition to that we have identified the presence of New Delhi Metalo- beta- lactamase in one of the clinical isolates. Conclusion: Rate of evolution in microbes is very high. Thus we presume that some of the amino acids in the functional domain of ?-lactamases have been changed respective to extinct use of penicillin whereas it is effective against clinically used other beta lactam antibiotics. DOI: http://dx.doi.org/10.3329/jbs.v19i0.12999 J. bio-sci. 19 37-42, 2011